日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)

尼拉帕尼和多斯塔利单抗治疗复发性铂耐药卵巢癌：II期研究结果（MOONSTONE/GOG-3032）

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2023.10.005
Randall, Leslie M; O'Malley, David M; Monk, Bradley J; Coleman, Robert L; Gaillard, Stephanie; Adams, Sarah; Duska, Linda R; Dalton, Heather; Holloway, Robert W; Huang, Marilyn; Chon, Hye Sook; Cloven, Noelle G; ElNaggar, Adam C; O'Cearbhaill, Roisin E; Waggoner, Steven; Tarkar, Aarti; Striha, Alina; Nelsen, Linda M; Baines, Amanda; Samnotra, Vivek; Konstantinopoulos, Panagiotis A
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

Laboratory-acquired infections in Canada from 2016 to 2021

2016年至2021年加拿大实验室感染病例

期刊:
影响因子:
doi:10.14745/ccdr.v48i78a02
El Jaouhari, Maryem; Striha, Megan; Edjoc, Rojiemiahd; Bonti-Ankomah, Samuel
炎症/感染
发表日期：2022
文献求助 收藏

Multivariate analyses of risk factors associated with laboratory exposure incidents

实验室暴露事件相关风险因素的多变量分析

期刊:
影响因子:
doi:10.14745/ccdr.v48i78a06
El Jaouhari, Maryem; Atchessi, Nicole; Edjoc, Rojiemiahd; Striha, Megan; Bonti-Ankomah, Samuel
发表日期：2022
文献求助 收藏

Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial

在随机、III期Myeloma XI试验中，对适合移植的所有年龄段患者进行自体干细胞移植前后的来那度胺治疗。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2020.247130
Jackson, Graham H; Davies, Faith E; Pawlyn, Charlotte; Cairns, David A; Striha, Alina; Collett, Corinne; Waterhouse, Anna; Jones, John R; Kishore, Bhuvan; Garg, Mamta; Williams, Cathy D; Karunanithi, Kamaraj; Lindsay, Jindriska; Allotey, David; Shafeek, Salim; Jenner, Matthew W; Cook, Gordon; Russell, Nigel H; Kaiser, Martin F; Drayson, Mark T; Owen, Roger G; Gregory, Walter M; Morgan, Gareth J; Clinical Studies Group, Uk Ncri Haematological Oncology
细胞生物学
发育与干细胞
干细胞
发表日期：2021
文献求助 收藏

Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later

儿童多系统炎症综合征快速回顾：一年后我们了解到的情况

期刊:
影响因子:
doi:10.14745/ccdr.v47i11a04
Striha, Megan; Edjoc, Rojiemiahd; Bresee, Natalie; Atchessi, Nicole; Waddell, Lisa; Bennett, Terri-Lyn; Thompson, Emily; El Jaouhari, Maryem; Bonti-Ankomah, Samuel
炎症/感染
炎症
发表日期：2021
文献求助 收藏

Surveillance of laboratory exposures to human pathogens and toxins, Canada 2020

加拿大2020年实验室接触人类病原体和毒素的监测

期刊:
影响因子:
doi:10.14745/ccdr.v47i10a04
Atchessi, Nicole; Striha, Megan; Edjoc, Rojiemiahd; Thompson, Emily; El Jaouhari, Maryem; Heisz, Marianne
微生物学
发表日期：2021
文献求助 收藏

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

在初诊多发性骨髓瘤患者中，采用环磷酰胺、硼替佐米和地塞米松进行反应适应性强化治疗与不进行强化治疗的疗效比较（骨髓瘤XI）：一项多中心、开放标签、随机、3期试验

期刊:Lancet Haematology
影响因子:17.7
doi:10.1016/S2352-3026(19)30167-X
Jackson, Graham H; Davies, Faith E; Pawlyn, Charlotte; Cairns, David A; Striha, Alina; Collett, Corinne; Waterhouse, Anna; Jones, John R; Kishore, Bhuvan; Garg, Mamta; Williams, Cathy D; Karunanithi, Kamaraj; Lindsay, Jindriska; Wilson, Jamie N; Jenner, Matthew W; Cook, Gordon; Kaiser, Martin F; Drayson, Mark T; Owen, Roger G; Russell, Nigel H; Gregory, Walter M; Morgan, Gareth J
多发性骨髓瘤
骨髓瘤
发表日期：2019
文献求助 收藏

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial

来那度胺治疗背景下的第二原发性恶性肿瘤：一项对参与 Myeloma XI 试验的 2732 例多发性骨髓瘤患者的分析

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2016.114
Jones, J R; Cairns, D A; Gregory, W M; Collett, C; Pawlyn, C; Sigsworth, R; Striha, A; Henderson, R; Kaiser, M F; Jenner, M; Cook, G; Russell, N H; Williams, C; Pratt, G; Kishore, B; Lindsay, J; Drayson, M T; Davies, F E; Boyd, K D; Owen, R G; Jackson, G H; Morgan, G J
多发性骨髓瘤
肿瘤
肿瘤免疫
骨髓瘤
发表日期：2016
文献求助 收藏